Investment & Capital Firms
MVM Life Science Partners LLP, founded in 1997, is a leading healthcare Venture Capital firm and manages three funds totaling over US$500 million. MVM invests broadly in the healthcare market including biopharmaceuticals, medical devices, drug platform technologies, diagnostics, drug delivery, OTC medicines, research tools, vaccines, and healthcare IT. MVM invests in start up and early stage companies as well as in companies with technologies in late stage clinical development or commercialization. MVM's investments are made predominately in Europe and the US. The MVM team has broad experience in healthcare Venture Capital and Private Equity investing and maintains offices in London and Boston.